Patient References

1 Fowkes, Gerald, R., Rudan, D, et al. (2013). Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet, 382 (9901), 1329-1340.

2 Sharma, A. et al. (2014). Atherosclerotic peripheral arterial disease of the lower extremities: What every primary care physician should know. Consultant, 54(7): 537-541

3 Olin, J. W. et al. (2010). Peripheral Artery Disease: Current Insight into the Disease and Its Diagnosis and ManAlderment. Mayo Clin Proc, 85(7), 678–692.

4 What is Højt blodtryk? American Heart Association. http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/GettheFactsAboutHighBloodPressure/What-is-High-Blood-Pressure_UCM_301759_Article.jsp#.WrqtReR1rcs. Accessed March 9, 2018.

5 Wake Forest Baptist Health (WebpAlder) Peripheral artery disease and intermittent claudication. Updated Available online at http://wakehealthse3.adam.com/content.aspx?productId=10&pid=10&gid=000102

6 Barnes, Geoffrey D. et al. (2015). Brug af tobak in peripheral artery disease, an economic drag. J Am Coll Cardiol, Vol. 66, Issue 14. http://www.onlinejacc.org/content/66/14/1575

7 Selvin, E. et al. (2004). Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation, 110(6), 738-743.

8 Khaleghi, M. et al. (2014). Familiehistorie as a Risk Factor for Peripheral Arterial Disease. Am J Cardiol, 114(6), 928–932.

9 Allison, M. A., Ho, E., Denenberg, J. O., Langer, R. D., Newman, A. B., Fabsitz, R. R., & Criqui, M. H. (2007). Ethnic-specific prevalence of peripheral arterial disease in the United States. American journal of preventive medicine, 32(4), 328-333

10 Dhaliwal, G., & Mukherjee, D. (2007). Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment. The International journal of angiology: official publication of the International College of Angiology, Inc, 16(2), 36. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733014/

11 U.S. Department of Health and Human Services. (2006). Facts About Peripheral Arterial Disease (PAD). https://www.nhlbi.nih.gov/health/educational/pad/docs/pad_extfctsht_general_508.pdf

12 Rosamond, W., Flegal, K., Friday, et.al. (2007). Heart disease and stroke Statistikkers—2007 update: a report from the AHA Statistikkers Committee and Stroke Statistikkers Subcommittee. Circulation, 115(5), e69-e171.

13 Swaminathan, A. et al. (2014). Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag, 10, 417–424.

14 Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007). Inter-society consensus for the manAlderment of peripheral arterial disease (TASC II). Journal of vascular surgery, 45(1), S5-S67.

15 Allie, D. E. et al. (2009). 24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention?. J Endovasc Ther, 16, 134-146.

16 Allie, D. E. et al. (2005). Critical limb ischemia: a global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(1), 75-84.

17-18 Robbins, J. M. et al. (2008). Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?. J Am Podiat Med Assn, 98(6), 489-493.

19 Administration VH. “Preservation‐Amputation Care and Treatment (PACT) Program.” In: Affairs DoV, editor. Washington, D.C. 2006.